The mislabeling poses a significant health risk, as patients receiving the drug could inadvertently be administered double ...
Dr. Reddys Laboratories is recalling a batch of Levetiracetam injection bags in the U.S. due to incorrect labeling, which ...
The potential risks include hypersensitivity reactions, liver injury, hematological toxicity, drowsiness, dizziness, ...
Dr Reddy’s Laboratories is recalling one batch of Levetiracetam in 0.75 percent Sodium Chloride Injection single-dose ...
Dennis Dlugos, MD, MSCE; Jacqueline French, MD; Terrence O'Brien, MD; Jo Sourbron, MD, PhD, MPharm; and Joseph Sullivan, MD, ...
Dr. Reddy's recalls Levetiracetam infusion bags in the U.S. due to mislabeling, posing risk of serious adverse effects.
Laboratories announced that it is recalling one Batch/Lot No: A1540076 of Levetiracetam in 0.75% Sodium Chloride Injection, 1 ...
Children in England living with a rare and severe form of epilepsy could soon benefit from a new drug being rolled out on the NHS. Fenfluramine has been recommended by the National Institute for ...
The government is planning to bring painkiller Tapentadol and epilepsy drug Pregabalin under strict control and monitoring to curb their misuse for substance abuse.
Dr. Reddy's Laboratories is recalling one Batch/Lot No: A1540076 of Levetiracetam in 0.75% Sodium Chloride Injection, 1,000 mg/100 mL (10 mg/mL) single-dose infusion bags to the consumer level, in the ...
Michael Lewis is the author, most recently, of “Going Infinite: The Rise and Fall of a New Tycoon.” His other works include ...